Eran Broshy Joins Providence Equity

Eran Broshy is a Senior Advisor of Providence. Prior to joining Providence in 2009, Mr. Broshy served as Chief Executive Officer of inVentiv Health, Inc. During his tenure at inVentiv, Mr. Broshy transformed the company into the leading provider of commercialization and complementary services to the global pharmaceutical and biotechnology industries. Mr. Broshy remains Executive Chairman of inVentiv.

Prior to joining inVentiv, Mr. Broshy served as a Partner at The Boston Consulting Group where he was responsible for the healthcare practice across the Americas. Mr. Broshy has also served as President and Chief Executive Officer of Coelacanth Corporation, a privately-held biotechnology company.

Mr. Broshy serves on the boards of Magellan Health Services, Neurogen Corporation, and on the Simon Wiesenthal Center’s NY Executive Board. Mr. Broshy received a Master of Business Administration from Harvard University, a Master of Science from Stanford University, and a Bachelor of Science from the Massachusetts Institute of Technology.